Quite agree JB. Nature, JAMA, The New England Journal of Medicine and Lancet surely the highest impact, peer reviewed medical journals.
This ain't gonna cut much mustard with most layman investors, but you simply don't get in these journals unless you have peer-reviewed medical credibility.
A second inclusion bodes very well for future progression in many quarters; commercial; academic; and professional.
Ann: Further GvHD Clinical Data Published in Nature Medicine, page-8
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
-0.005(2.22%) |
Mkt cap ! $40.68M | |||
| Open | High | Low | Value | Volume |
| 22.5¢ | 22.5¢ | 22.0¢ | $32.84K | 146.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 6640 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.5¢ | 16723 | 1 |
View Market Depth
| Last trade - 14.56pm 19/11/2024 (20 minute delay) ? |
| CYP (ASX) Chart |